Literature DB >> 19661044

Primary squamous cell carcinoma of the breast: achieving long-term control with cisplatin-based chemotherapy.

Lubna Bhatt1, Indrajit Fernando.   

Abstract

Pure primary squamous cell carcinoma (SCC) of the breast is rare and difficult to treat. Published series suggest a poor response to conventional breast chemotherapy. A 66-year-old woman with locally advanced SCC of the breast received combined-modality treatment with high-dose radiation therapy (59 Gy in 22 fractions); mastectomy; and chemotherapy with cisplatin 50 mg/m(2), mitomycin-C 6 mg/m(2), and ifosfamide 3 g/m(2) given in 21-day cycles. She remained disease free for 10 years from presentation and died from an unrelated cause. We would suggest that this case lends support to the use of high-dose radiation therapy and platinum-based chemotherapy in the management of this difficult condition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661044     DOI: 10.3816/CBC.2009.n.031

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  6 in total

Review 1.  Management of unusual histological types of breast cancer.

Authors:  Karen A Cadoo; Orla McArdle; Anne-Marie O'Shea; Colm P Power; Bryan T Hennessy
Journal:  Oncologist       Date:  2012-07-23

2.  Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast.

Authors:  Jin Wang; Xinke Zhang; Jiehua He; Mingtian Yang; Jun Tang; Xing Li; Hailin Tang; Xiaoming Xie
Journal:  Med Oncol       Date:  2014-08-15       Impact factor: 3.064

3.  Primary squamous cell carcinoma of the breast: report of two cases with HER2 overexpression.

Authors:  Ruixue Lei; Lanfang Miao
Journal:  Cancer Biol Ther       Date:  2020-11-12       Impact factor: 4.742

4.  Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report.

Authors:  Yong Cao; Yeli Yue; Xin Zhou; Jie Luo; Xiaohua Zeng; JuanHui Dong; Xinrui Liang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review.

Authors:  Baolin Chen; Yan Jiang; Chengmin Luo; Yuxiang Bao; Na Tan; Taolang Li; Xiaoming Cheng; Junyuan Lv
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

6.  Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.

Authors:  Rilan Bai; Lin Jia; Yangyang Gao; Xu Sun; Naifei Chen; Zheng Lv; Jiuwei Cui
Journal:  Thorac Cancer       Date:  2022-08-16       Impact factor: 3.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.